コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ssenger RNA (mRNA) levels were determined by ribonuclease protection assay.
2 control by high-sodium diet, as indicated by ribonuclease protection assay.
3 nd KGF receptor transcripts were analyzed by ribonuclease protection assay.
4 ype 1 receptor mRNA were analyzed, using the ribonuclease protection assay.
5 fabH promoter were quantified by employing a ribonuclease protection assay.
6 icrodissected brain regions by a microlysate ribonuclease protection assay.
7 tion sites were identified by S1 mapping and ribonuclease protection assay.
8 actor Tu (EF-Tu).GTP were determined using a ribonuclease protection assay.
9 and real-time polymerase chain reaction and ribonuclease protection assay.
10 e receptors, and CD markers were measured by ribonuclease protection assay.
11 3, 5, and 7 after grafting, as measured by a ribonuclease protection assay.
12 R-x1- miR-x4), either by northern blot or by Ribonuclease Protection Assay.
13 elongation factor Tu (EF-Tu)*GTP by using a ribonuclease protection assay.
14 their respective mRNA levels, as measured by ribonuclease protection assay.
15 of CCR1 and CCR3 mRNA in PMN was detected by ribonuclease protection assay.
16 D receptor null mutant mice was confirmed by ribonuclease protection assay.
17 iary body from inflamed eyes was analyzed by ribonuclease protection assay.
18 of the corresponding mRNAs was confirmed by ribonuclease protection assay.
19 ide sequencing, semiquantitative RT-PCR, and ribonuclease protection assay.
20 with HIV-1 LTR transcription, as measured by ribonuclease protection assay.
21 dated by using reverse transcription-PCR and ribonuclease protection assay.
22 l carcinoma cell line P19 was confirmed in a ribonuclease protection assay.
23 replicative intermediates, was confirmed by ribonuclease protection assay.
24 ventricular ACE mRNA levels were measured by ribonuclease protection assay.
25 Endothelial mRNA levels were assessed using ribonuclease protection assays.
26 ls of alpha-tubulin mRNA, as demonstrated by ribonuclease protection assays.
27 e sensitive than either northern blotting or ribonuclease protection assays.
28 h with cell-free translation assays and with ribonuclease protection assays.
29 F) was examined by in situ hybridization and ribonuclease protection assays.
30 ynechococcus sp. PCC 7002 were studied using ribonuclease protection assays.
31 olic binding protein (IBABP) was assessed by ribonuclease-protection assays.
32 evels among IS, IR, and NIDDM groups using a ribonuclease protection assay (0.22 +/- 0.06, 0.13 +/- 0
35 sion and protein levels were determined with ribonuclease protection assay and ELISA, respectively.
42 d mRNA splicing variants in human tissues by ribonuclease protection assays and found that some varia
43 promoter::beta-glucuronidase (GUS) fusion by ribonuclease protection assays and GUS histochemical sta
45 n bovine and human RPE were identified using ribonuclease protection assays and reverse transcriptase
48 istribution of DGKeta message (determined by ribonuclease protection assays) and protein (determined
49 cted in spleen, thymus, and adrenal gland by ribonuclease protection assay, and discrete sites of exp
50 ere characterized by northern blot analysis, ribonuclease protection assay, and enzyme-linked immunos
51 ase chain reaction, IGF-I mRNA expression by ribonuclease protection assay, and IGFBP-1 to -4 mRNA ex
52 , quantitative real-time PCR, Northern blot, ribonuclease protection assay, and monocistronic reporte
53 Northern blot, polymerase chain reaction or ribonuclease protection assay, and their cellular origin
54 brane vesicles and Northern blot, slot blot, ribonuclease protection assay, and Western blot analyses
55 n differentiating xylem, as assessed by both ribonuclease protection assays, and by northern blot ana
56 orneal VEGF mRNA levels were quantified with ribonuclease protection assays, and VEGF protein was stu
57 issue, WNT10B expression was not detected by ribonuclease protection assays but was found at low leve
59 precursors in R. prowazekii, as analyzed by ribonuclease protection assays, decreased significantly
60 sette exon that encodes the ET site and with ribonuclease protection assays demonstrate that the expr
62 lysis of an S100A1 promoter-CAT construct by ribonuclease protection assay demonstrated that this gen
66 ne as detected by reverse transcription-PCR, ribonuclease protection assay, direct epifluorescence, i
68 ed LDL [ox-LDL]) by use of Northern blot and ribonuclease protection assays for mRNA, Western blot an
70 e J774 mouse macrophage cell line by RT-PCR, ribonuclease protection assay, immunoblotting, and immun
71 RNA, protein, and bioactivity as assessed by ribonuclease protection assay, immunoblotting, and zymog
72 n-polymerase chain reaction and quantitative ribonuclease protection assays; immunohistochemistry con
76 ymerase chain reaction and used as probes in ribonuclease protection assays of RNA from a fiber devel
77 red from the endothelial cells and tested by ribonuclease protection assay or Northern blot hybridiza
78 to clusters of differentiated cells, whereas ribonuclease protection assays performed on heterogeneou
86 n of cDNA ends (RACE), primer extension, and ribonuclease protection assay (RPA) a single transcripti
88 analyzed for TF-specific mRNA expression by ribonuclease protection assay (RPA), surface TF expressi
92 receptor gene expression were determined by ribonuclease protection assays (RPA) at 6 hours and at 3
94 lay reverse transcription PCR (DDRT-PCR) and ribonuclease protection assays (RPA), we identified a cD
104 ominant start sites for each transcript, and ribonuclease protection assays showed the presence of on
105 transcription polymerase chain reaction, and ribonuclease protection assays, significant increases in
109 nt of the rat forebrain using 1) a sensitive ribonuclease protection assay to distinguish full-length
111 s used in conjunction with a high-throughput ribonuclease protection assay to investigate the thermod
123 n of the L2 transcript, primer extension and ribonuclease protection assays were used to identify tra
124 levels of CYP4C7 mRNA in the CA, measured by ribonuclease protection assays, were linked to the activ
125 ein and VIP-binding activity, as assessed by ribonuclease protection assays, Western blots, and bindi
126 transcription polymerase chain reaction and ribonuclease protection assay with little or no change i
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。